PO.CL01.12 · 临床研究

Imaging mass cytometry of pelareorep treated early breast cancer samples reveals developing tertiary lymphoid structures

海报缩略图:Imaging mass cytometry of pelareorep treated early breast cancer samples reveals developing tertiary lymphoid structures
编号 1221 展板 22 时间 4/19 02:00–05:00 区域 Section 47 主讲 Julian Olea, BS;MS
分会场 Spatial Proteomics and Transcriptomics 1
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Julian P. Olea1, Homa Dadrastoussi1, Kaijin Wu1, Harley Wu1, Paniz Zarand1, Claudia Villa Celi1, Jennifer S. Carew2, Steffan T. Nawrocki2, Xuelian Chen1, Richard Trauger3, Thomas C. Heineman3, Kevin R. Kelly1

1Hematology, Keck School of Medicine of USC, Los Angeles, CA,2Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ,3Oncolytics Biotech, Inc., Calgary, AB, Canada

摘要 Abstract

AWARE-1 is a window-of-opportunity study evaluating the effects of the oncolytic virus (OV) pelareorep in early-stage breast cancer patients. This analysis focuses on Cohort 2 (n = 8), consisting of HR+ HER2- patients who received pelareorep on days 1, 2, 8, 9; letrozole on days 1-21; and atezolizumab on day 3. Biopsies were collected pre-treatment, on day 3, and on day 21. Tissue was stained using an imaging mass cytometry (IMC) antibody cocktail targeting a variety of immune cell subsets to characterize changes over time in the tumor immune microenvironment (TiME) and the subsequent development of tertiary lymphoid structures (TLS) in select subjects. Unsupervised PhenoGraph clustering identified 18 distinct phenotypes, including T helper (Th), activated T helper (ATh), cytotoxic T cells (CTC), B cells (BC), differentiated B cells (DBC), and dendritic cells (DC). CTC's were significantly increased from screening to day 21 samples (p = 0.04) and from day 3 to day 21 samples (p = 0.04). Further analysis of these cell types and how they interact is performed using cellular neighborhood analysis, which identifies common arrangements of certain cell types throughout the samples. Cellular neighborhood analysis yielded an interesting neighborhood cluster comprising CTC, DC, TH, BC, DBC, and M2 Mac cells - defined as the TLS neighborhood. Visualization of the TLS neighborhood showed progressing stages of T cell and B cell organization, with T cells and B cells being largely diffuse and unstructured at screening and concentrating into zones of BC - BC aggregates surrounded by CTC, TH, and ATH cells at day 21. Pairwise permutation-based interaction analysis was applied to the cells comprising the TLS neighborhood to validate significant biological organization. At day 21 BC - TH, DBC - BC, and DBC - DBC interactions were significantly more likely to occur than at screening. Other interactions of note were between tumor - ATH, tumor - CTC, tumor - DC, CTC - ATH, and CTC - CTC interactions were significantly increased at surgery. This study is the first of its kind to identify and spatially validate the unique cell-cell interactions in the TiME of early breast cancer patients treated with the OV pelareorep as developing TLS's, highlighting coordinated TiME reorganization and novel cell-cell interaction dynamics associated with TLS formation.
利益披露 Disclosure
J. P. Olea, NIH/National Cancer Center ). Roche (RHBY) Stock. Anneal (AMRX) Stock. Sarepta (SRPT) Stock. H. Dadrastoussi, NIH/National Cancer Center ). K. Wu, NIH ). H. Wu, None.. P. Zarand, None.. C. Villa Celi, None. J. S. Carew, Majestic Therapeutics Other, Support. S. T. Nawrocki, Majestic Therapeutics Other, Support. X. Chen, None. R. Trauger, Oncolytics Biotech, Inc. Employment. T. C. Heineman, Oncolytics Biotech, Inc. Employment. K. R. Kelly, Oncolytics Biotech Inc. ). National Cancer Center Core Grants ). Ming Hsieh Institute at the University of Southern California ). Merck ). Whittier Initiative at the University of Southern California–Translational Research ). Takeda ). Janssen Gift. Ipsen Biopharmaceuticals Gift. AstraZeneca Gift. Karyopharm Therapeutics Gift. Servier Pharmaceuticals Gift. Gilead Sciences Inc. Gift. Seagen Inc. Gift. Eli Lilly and Company Gift. Bristol-Myers Squibb Gift. GSK Gift. AbbVie Gift. ACI Clinical Gift. Denovo Biopharma Gift. Incyte Pharmaceuticals Gift.

在会议检索中打开